Korsch
Korsch AG is a German manufacturer of pharmaceutical tablet compression machinery, offering research-scale to high-speed production presses with proprietary containment and process control systems for pharmaceutical, food, chemical, and technical industries worldwide.
- Company typePrivate
- Founded1900
- HeadquartersBerlin, Germany
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What Korsch does
Korsch Aktiengesellschaft (Korsch AG) is a Berlin-based German engineering company that designs, develops, and manufactures rotary tablet compression machinery, founded around 1900 and operating for more than 100 years. The company serves pharmaceutical manufacturers as its primary customer segment, with additional verticals in food and confectionery, chemical, and technical applications (batteries, catalysts, airbag components, magnets, sintered metals). Its product portfolio spans the full product lifecycle from research-scale presses (XP 1, EK 2, STYL'ONE Evo family) through scale-up and high-speed production systems (X3, XM12, XL 400, XT 300), with output capacities reaching 324,000 tablets per hour on flagship models.
Korsch's technology platform centers on proprietary systems including the PharmaControl press force control system for real-time weight monitoring, DryCon and WipCon containment technologies meeting OEB 4-5 standards for highly potent active pharmaceutical ingredients (HPAPIs), and Industry 4.0-compatible Siemens-based control architectures. The company operates the Berlin Innovation Center for formulation development, process optimization, and scale-up support, and complements its equipment with strategic partnerships covering compaction simulation (MEDELPHARM) and granulation/coating/continuous manufacturing (L.B. BOHLE).
The business model is built on direct hardware sales of capital equipment, distributed through wholly-owned subsidiaries in Germany, the United States, India, South Korea, and Indonesia, supplemented by a global network of regional distributors and agents. Pricing is quote-based and not publicly disclosed. The company is privately held with no disclosed external venture or private equity investment, serves a 10,000+ installed base of customers globally, and emphasizes enterprise field sales with dedicated regional contacts and full lifecycle support from R&D through to 24/7 production.
Korsch firmographics
Firmographics- Name
- Korsch
- Legal name
- Korsch Aktiengesellschaft
- Website
- https://korsch.com
- Company type
- Private
- Founded year
- 1900
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Korsch AG is a German manufacturer of pharmaceutical tablet compression machinery, offering research-scale to high-speed production presses with proprietary containment and process control systems for pharmaceutical, food, chemical, and technical industries worldwide.
- Ownership category
- akta.pro rank
Korsch industry classification
Industry- Product category
- Pharmaceutical Tablet Press Equipment
- akta.pro primary industry
- Filling & Dosing Machines (Liquid/Powder/Solid) (IMAHAOAF)
- akta.pro secondary industry
- Filling & Dosing Equipment (Liquid, Powder, Aseptic) (IMALAOAB)
Keywords
Where Korsch is headquartered
LocationHeadquarters
- HQ city
- Berlin
- HQ country
- Germany
- HQ region
- Europe
Offices5 records
Markets served
Korsch business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Personnel, Operations, Infrastructure, Marketing or Sales
Revenue model
- Tablet Press Equipment Sales: Korsch generates revenue through the sale of tablet press machinery and equipment, including research presses, scale-up systems, and high-speed production presses. The company also offers customization options, containment solutions, and related peripheral equipment.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
Korsch product offering
Product offeringCore offering
Korsch designs, develops, and manufactures rotary tablet press machinery used to compress powders into tablets for the pharmaceutical, food and confectionery, chemical, and technical industries. The product line spans research-scale presses (XP 1, EK 2, STYL'ONE Evo family) to high-speed production presses (X3, XM12, XL 400, XT 300), complemented by proprietary containment solutions (WipCon, DryCon) and the PharmaControl press force control system, with a Berlin-based Innovation Center supporting formulation development, process optimization, and scale-up services.
Product overview
Korsch is a tablet compression specialist offering a comprehensive portfolio of pharmaceutical tablet presses spanning from R&D to full-scale production. The product line includes research presses (XP 1, EK 2, STYL'ONE Evo family), production presses (X3, XM12, XL 400, XT 300), and specialized containment solutions (WipCon, DryCon). Korsch provides the entire tableting ecosystem including the PharmaControl press force control system and Innovation Center services for formulation development, process optimization, and scale-up support. The company serves pharmaceutical, food & confectionery, chemical, and technical industries with over 10,000 installed tablet presses worldwide.
Differentiator
Problem solved
Functional benefit
Products and services
- Korsch XL 400 High-performance tablet press designed for full-scale 24/7 production environments in pharmaceutical, food, chemical, and technical applications.
- Korsch XP 1 Small-scale research tablet press used for feasibility studies with very small material quantities, evaluating flow, compressibility, and content uniformity of formulations.
- EK 2 Tablet press designed for very large tablet formats, used for feasibility studies and formulation development.
- Korsch X3 High-containment tablet press featuring Band 5 containment capabilities for safe manufacture of highly potent active pharmaceutical ingredients (HPAPIs) at clinical and commercial scales, supporting complex oral solid dosage therapies.
- Korsch XM12 Production tablet press used by pharmaceutical manufacturers for technological advancement in tablet production capabilities.
- Korsch XT 300 Tablet Press Compact single-sided high-speed rotary tablet press that serves as an entry platform into Korsch production technology, achieving outputs up to 324,000 tablets per hour with up to 80 kN main compression force.
- STYL'ONE Evo Research and development tablet press platform used for compaction studies and formulation optimization, available in multiple configurations and capable of meeting OEB 5 containment requirements when configured with WipCon technology.
- STYL'ONE Nano WipCon Compact R&D tablet press with WipCon containment technology meeting OEB 5 requirements for handling highly potent compounds.
- STYL'ONE Evo WipCon R&D tablet press with WipCon containment system meeting OEB 5 requirements, featuring integrated weighing and measuring capabilities inside the isolator.
- STYL'ONE Evo DryCon R&D tablet press with DryCon single- and multilayer compaction technology, featuring glove ports and optional isolator configuration for OEB 4 containment.
- WipCon Containment System Proprietary containment solution meeting OEB 5 requirements using innovative misting technology that binds dust particles, providing operator protection and reducing cleaning effort for tablet production with highly potent active ingredients.
- DryCon Containment System Proprietary economical containment solution using innovative misting technology for tablet production up to OEB level 4, featuring a Restricted Access Barrier System (RABS) with negative pressure control, glove ports, and Rapid Transfer Port (RTP).
- PharmaControl Press Force Control System Proprietary press force control system ensuring precise tablet weight control through continuous monitoring of individual compression forces with real-time display of average and individual forces.
- Korsch Innovation Center Services Technical service facility in Berlin equipped with the latest Korsch tablet presses, peripherals, in-process test equipment, analytical equipment, and powder processing technology, supporting formulation development, process optimization, scale-up, and feasibility studies for customers.
Quantifiable outcome
- Up to 324,000 tablets per hour output with XT 300 press
- +1 more outcomes
Companies that use Korsch
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles4 records
Korsch technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Korsch partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- MEDELPHARMcoreStrategic partnership integrating MEDELPHARM compaction simulator technology into Korsch's equipment portfolio. This partnership adds important development capabilities permitting streamlined material characterization and predictive studies on high-speed performance with minimal material quantities. Korsch Innovation Center works closely with MEDELPHARM's Science Lab in Lyon, France.
- L.B. BOHLEcoreStrategic partnership with L.B. BOHLE adds expertise around upstream and downstream processes including granulation, roller compacting, tablet coating, and continuous manufacturing systems. Korsch customers benefit from access to the LB BOHLE Technology Center in Ennigerloh, Germany.
- Technical UniversitiesminorJoint research projects with technical universities supporting product development and innovation in tablet compression technology.
Scale indicators2 records
Recent moves6 records
Expansion highlights5 records
Korsch competitors and assessment
Company assessmentDirect peers
- Fette Compacting: German-headquartered specialist in tablet press technology serving the same pharmaceutical and related compression customers as Korsch. It is the closest direct competitor, competing head-to-head on rotary presses, containment, and high-speed production platforms.
- Thomas Engineering: US-based manufacturer of tablet presses (including the PrecisePress and Elite lines) and related tablet tooling. Thomas Engineering is a direct peer competing primarily in mid-volume and specialty tablet compression, with overlap on containment applications.
- Bausch + Ströbel: German manufacturer of pharmaceutical processing and packaging machinery, including filling, closing, and containment systems for injectables and solid dose. While more focused on filling, it competes with Korsch on containment solutions for HPAPIs and complex oral solid dose formats.
- Romaco Group: Pharmaceutical processing and packaging equipment supplier offering tablet presses, granulation, and coating systems. Romaco is a direct peer to Korsch in mid- to high-volume tablet production, particularly in European markets.
- L.B. Bohle: German manufacturer of granulation, drying, coating, and continuous manufacturing equipment, and Korsch's strategic partner for end-to-end tableting lines. L.B. Bohle is both a complement and a competitor on the integrated solutions Korsch pitches to pharma customers.
- Glatt Group: Family-owned German specialist in pharmaceutical process technology, including fluid bed granulation, coating, and tablet production equipment. Glatt competes with Korsch in upstream/downstream tableting and integrated continuous manufacturing solutions.
Broad incumbents
- Syntegon Technology: Formerly Bosch Packaging Technology, Syntegon provides processing and packaging equipment for pharmaceuticals, including tablet presses and containment systems. It is a broad incumbent with similar customer overlap to Korsch in oral solid dose manufacturing.
- GEA Pharma & Healthcare: Part of the diversified GEA Group, offering tablet presses alongside granulation, containment and continuous manufacturing systems for pharma. It competes with Korsch on integrated tableting lines and leverages a much larger balance sheet and global service network.
- IMA Group: Italian leader in processing and packaging machinery for the pharma and food industries, with a broad tableting and containment portfolio. IMA competes with Korsch especially on integrated solutions for high-containment oral solid dose manufacturing.
Emerging players
- MG America (Truking): North American arm of Chinese pharmaceutical equipment group Truking, offering tablet presses and solid dose processing equipment. It competes with Korsch on price-sensitive and emerging-market deals, particularly for generic manufacturers in Asia and the Americas.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Korsch social profiles
Digital presenceKorsch financial estimates
Financial estimateRevenue estimate
Valuation estimate
Korsch leadership team
Management profileNumber of profiles
Profiles15 records
Korsch subsidiaries and ownership
Company hierarchySubsidiaries4 records
Korsch funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Korsch M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Korsch
What does Korsch do?
Korsch designs, develops, and manufactures rotary tablet press machinery used to compress powders into tablets for the pharmaceutical, food and confectionery, chemical, and technical industries. The product line spans research-scale presses (XP 1, EK 2, STYL'ONE Evo family) to high-speed production presses (X3, XM12, XL 400, XT 300), complemented by proprietary containment solutions (WipCon, DryCon) and the PharmaControl press force control system, with a Berlin-based Innovation Center supporting formulation development, process optimization, and scale-up services.
Is Korsch a public or private company?
Korsch is a private company. It is classified as family owned and is currently operating.
When was Korsch founded?
Korsch was founded in 1900. It employs 251 to 500 people.
Where is Korsch based?
Korsch is headquartered in Berlin, Germany, in the Europe region.
How does Korsch make money?
One revenue line is on record: tablet Press Equipment Sales.
Who are Korsch's main competitors?
Direct peers on record are Fette Compacting, Thomas Engineering, Bausch + Ströbel, Romaco Group, L.B. Bohle and Glatt Group. Broad incumbents are Syntegon Technology, GEA Pharma & Healthcare and IMA Group. MG America (Truking) is listed as an emerging player.
Does Korsch have an API?
No public API is recorded for Korsch.
What industry is Korsch in?
Korsch's product category is Pharmaceutical Tablet Press Equipment. Its primary akta.pro industry code is IMAHAOAF, Filling & Dosing Machines (Liquid/Powder/Solid), with a secondary code of IMALAOAB, Filling & Dosing Equipment (Liquid, Powder, Aseptic).